Putnam Investments’s Neos Therapeutics, Inc NEOS Stock Holding History

Putnam Investments’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-116,038	Closed	-$679K	–	1305
2016 Q4	$679K	Sell	116,038 -98,962	-46%	-$670K	﹤0.01%	1078
2016 Q3	$1.42M	Hold	215,000	–	–	﹤0.01%	937
2016 Q2	$2M	Hold	215,000	–	–	﹤0.01%	931
2016 Q1	$2.32M	Hold	215,000	–	–	0.01%	904
2015 Q4	$3.08M	Hold	215,000	–	–	0.01%	853
2015 Q3	$4.52M	Buy	+215,000	New	+$4.74M	0.01%	704

Other funds holding NEOS

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Putnam Investments's NEOS Position: Q1 2017 in Review

Putnam Investments sold out of Neos Therapeutics, Inc (NEOS) in Q1 2017, closing a stake of 116,038 shares — an estimated $679K sold.

Putnam Investments first reported a position in NEOS in Q3 2015 and held it in 6 quarters. The position peaked at $4.52M in Q3 2015. 49 funds tracked by Wall St. Rank hold NEOS as of Q1 2017.

Putnam Investments reported no remaining Neos Therapeutics, Inc position as of Q1 2017 after selling out during the quarter.
Putnam Investments sold 116,038 Neos Therapeutics, Inc shares in Q1 2017, an estimated $679K.
Putnam Investments first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 6 quarters.
Putnam Investments's Neos Therapeutics, Inc position peaked at $4.52M in Q3 2015.
49 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2017.

Based on Putnam Investments's 13F filing for Q1 2017, filed 15 May 2017.